当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析

奥翔药业

(603229)

  

流通市值:67.17亿  总市值:67.17亿
流通股本:8.30亿   总股本:8.30亿

奥翔药业(603229)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.19亿元,每股收益0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益237177.36万元,未分配利润97366.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产312055.87万元,负债74878.51万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入306,636,220.57795,288,308.9690,126,439.62492,393,814.37
营业总成本169,849,438.7575,480,342.93436,562,072.07282,548,002.93
营业利润136,769,869.82241,143,575.95261,919,470.22208,115,873.58
利润总额136,732,467.33240,200,048.65261,279,487.39207,568,953.89
净利润119,199,188.77206,791,017.22228,985,673.66179,832,394.24
其他综合收益670,246.5329,582.577,367.7315,617.25
综合收益总额119,869,435.3206,820,599.79228,993,041.39179,848,011.49
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,836,403,912.681,709,169,547.871,736,464,361.511,704,319,349.55
非流动资产合计1,284,154,799.931,273,220,502.521,281,159,560.141,276,313,392.85
资产总计3,120,558,712.612,982,390,050.393,017,623,921.652,980,632,742.4
流动负债合计714,430,201.79674,525,715.76686,271,542.48622,648,602.88
非流动负债合计34,354,931.3335,973,131.9237,288,734.8636,559,573.93
负债合计748,785,133.12710,498,847.68723,560,277.34659,208,176.81
归属于母公司股东权益合计2,371,773,579.492,271,891,202.712,294,063,644.312,321,424,565.59
股东权益合计2,371,773,579.492,271,891,202.712,294,063,644.312,321,424,565.59
负债和股东权益合计3,120,558,712.612,982,390,050.393,017,623,921.652,980,632,742.4
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计260,035,698.68853,563,748.87611,796,197.96376,608,417.96
经营活动现金流出小计257,989,311.38675,637,971.51527,892,685.96337,676,124
经营活动产生的现金流量净额2,046,387.3177,925,777.3683,903,51238,932,293.96
投资活动现金流入小计5,947,942.7237,602,044.9411,517,089.343,435,600.31
投资活动现金流出小计36,820,547.22157,570,981.9797,166,549.757,198,361.14
投资活动产生的现金流量净额-30,872,604.5-119,968,937.03-85,649,460.36-53,762,760.83
筹资活动现金流入小计89,790,810.84290,812,726.52170,100,00070,100,000
筹资活动现金流出小计104,874,200.35399,032,612.08257,264,842.07178,912,623.02
筹资活动产生的现金流量净额-15,083,389.51-108,219,885.56-87,164,842.07-108,812,623.02
汇率变动对现金及现金等价物的影响3,875,717.8110,842,676.45-5,520,623.061,936,785.41
现金及现金等价物净增加额-40,033,888.9-39,420,368.78-94,431,413.49-121,706,304.48
期末现金及现金等价物余额1,008,547,330.251,048,581,219.15993,570,174.44966,295,283.45
最新报告期:2025-04-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,乔露阳0.340.400.492025-04-29
TOP↑